SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Cognetix
Cognetix explored the use of snail toxins for the treatment of epilepsy, pain and anesthesia.
Cognetix
Salt Lake City, UT
